These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37025588)

  • 1. A novel
    Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
    Front Oncol; 2023; 13():1102184. PubMed ID: 37025588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
    de la Hoya M; Soukarieh O; López-Perolio I; Vega A; Walker LC; van Ierland Y; Baralle D; Santamariña M; Lattimore V; Wijnen J; Whiley P; Blanco A; Raponi M; Hauke J; Wappenschmidt B; Becker A; Hansen TV; Behar R; Investigators K; Niederacher D; Arnold N; Dworniczak B; Steinemann D; Faust U; Rubinstein W; Hulick PJ; Houdayer C; Caputo SM; Castera L; Pesaran T; Chao E; Brewer C; Southey MC; van Asperen CJ; Singer CF; Sullivan J; Poplawski N; Mai P; Peto J; Johnson N; Burwinkel B; Surowy H; Bojesen SE; Flyger H; Lindblom A; Margolin S; Chang-Claude J; Rudolph A; Radice P; Galastri L; Olson JE; Hallberg E; Giles GG; Milne RL; Andrulis IL; Glendon G; Hall P; Czene K; Blows F; Shah M; Wang Q; Dennis J; Michailidou K; McGuffog L; Bolla MK; Antoniou AC; Easton DF; Couch FJ; Tavtigian S; Vreeswijk MP; Parsons M; Meeks HD; Martins A; Goldgar DE; Spurdle AB
    Hum Mol Genet; 2016 Jun; 25(11):2256-2268. PubMed ID: 27008870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
    Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
    Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of prospectively demonstrated phenocopies in
    Dominguez-Valentin M; Evans DGR; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E
    Hered Cancer Clin Pract; 2018; 16():4. PubMed ID: 29371908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
    Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
    Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.
    Yang C; Jairam S; Amoroso KA; Robson ME; Walsh MF; Zhang L
    Breast Cancer Res Treat; 2018 Apr; 168(2):543-550. PubMed ID: 29185120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.
    Ruiz de Garibay G; Fernandez-Garcia I; Mazoyer S; Leme de Calais F; Ameri P; Vijayakumar S; Martinez-Ruiz H; Damiola F; Barjhoux L; Thomassen M; Andersen LVB; Herranz C; Mateo F; Palomero L; Espín R; Gómez A; García N; Jimenez D; Bonifaci N; Extremera AI; Castaño J; Raya A; Eyras E; Puente XS; Brunet J; Lázaro C; ; ; Radice P; Barnes DR; Antoniou AC; Spurdle AB; de la Hoya M; Baralle D; Barcellos-Hoff MH; Pujana MA
    Hum Mutat; 2021 Nov; 42(11):1488-1502. PubMed ID: 34420246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays.
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Acedo A; Velasco EA
    Front Genet; 2018; 9():188. PubMed ID: 29881398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of
    Farber-Katz S; Hsuan V; Wu S; Landrith T; Vuong H; Xu D; Li B; Hoo J; Lam S; Nashed S; Toppmeyer D; Gray P; Haynes G; Lu HM; Elliott A; Tippin Davis B; Karam R
    Front Oncol; 2018; 8():286. PubMed ID: 30101128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent triple-negative breast cancer with germline pathogenic variants in both
    Chen D; Zhang C; Yuan M; Zhang Y; Liu Q; Wan D
    Front Oncol; 2022; 12():970641. PubMed ID: 36518309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: A novel
    Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
    Front Oncol; 2023; 13():1306238. PubMed ID: 37936611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.
    Ahlborn LB; Dandanell M; Steffensen AY; Jønson L; Nielsen FC; Hansen TV
    Breast Cancer Res Treat; 2015 Apr; 150(2):289-98. PubMed ID: 25724305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events.
    de Jong LC; Cree S; Lattimore V; Wiggins GAR; Spurdle AB; ; Miller A; Kennedy MA; Walker LC
    Breast Cancer Res; 2017 Nov; 19(1):127. PubMed ID: 29183387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.
    Andrés R; Menao S; Arruebo M; Quílez E; Cardiel MJ
    Breast Cancer Res Treat; 2019 Oct; 177(3):767-770. PubMed ID: 31292799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel pathogenic variant in
    Laraqui A; Cavaillé M; Uhrhammer N; ElBiad O; Bidet Y; El Rhaffouli H; El Anaz H; Rahali DM; Kouach J; Guelzim K; Badaoui B; AlBouzidi A; Oukabli M; Tanz R; Sbitti Y; Ichou M; Ennibi K; Sekhsokh Y; Bignon YJ
    J Genomics; 2021; 9():43-54. PubMed ID: 34646395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
    Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
    BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.